 |
Corporate News
14-Jul-21
|
|
|
|
|
|
|
|
|
|
|
|
Caplin Sterlies receives USFDA final approval for Sumatriptan Injection
|
|
|
|
|
|
|
|
Caplin Point Laboratories announced that its subsidiary, Caplin Sterlies, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)
Sumatriptan Injection USP, 6 mg/0.5 mL (12 mg/mL) Single dose Vials, a generic therapeutic equivalent version of (RLD), IMITREX Injection, of GlaxoSmithKline, USA.
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache. According to IQVIATM (IMS Health), Sumatriptan Injection had US sales data of approximately $5 million for the 12-month period ending March 2021, for Vial presentation.
|
|
|
|
Previous News |
Volumes jump at Caplin Point Laboratories Ltd counter
(
Hot Pursuit
-
01-Oct-24
14:30
)
|
|
|
Motilal Oswal Financial Services Ltd leads gainers in 'A' group
(
Hot Pursuit
-
26-Aug-24
12:00
)
|
|
|
Volumes spurt at Caplin Point Laboratories Ltd counter
(
Hot Pursuit
-
19-Aug-24
14:30
)
|
|
|
Caplin Point Laboratories Ltd leads gainers in 'A' group
(
Hot Pursuit
-
19-Aug-24
12:00
)
|
|
|
Volumes soar at Hindustan Zinc Ltd counter
(
Hot Pursuit
-
19-Aug-24
11:00
)
|
|
|
Benchmarks trades with small gains; media shares in demand
(
Market Commentary
-
Mid-Session
19-Aug-24
10:33
)
|
|
|
Caplin Point hits life high after Chennai unit clears Brazilian Agency’s inspection
(
Hot Pursuit
-
19-Aug-24
09:46
)
|
|
|
Caplin Point Chennai unit clears Brazilian Agency’s inspection
(
Hot Pursuit
-
17-Aug-24
17:07
)
|
|
|
Caplin Point Laboratories to convene AGM
(
Corporate News
-
07-Aug-24
16:31
)
|
|
|
Board of Caplin Point Laboratories recommends final dividend
(
Corporate News
-
07-Aug-24
16:31
)
|
|
|
Caplin Point Laboratories consolidated net profit rises 19.86% in the June 2024 quarter
(
Results
-
Announcements
07-Aug-24
15:14
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|